Tazolol Chemical compound Pharmaceutical compound Tazolol is a beta blocker with some utility in the treatment of heart disease.[1] See also Timolol Niridazole Fenclozic acid References ^ Strosberg AM (August 1976). "The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant". Archives Internationales de Pharmacodynamie et de Therapie. 222 (2): 200–15. PMID 010864. Sympatholytic (and closely related) antihypertensives (C02)Sympatholytics(antagonize α-adrenergicvasoconstriction)Centralα2-Adrenergic receptor agonists Clonidine Guanabenz Guanfacine Guanoxabenz Methyldopa# Tiamenidine‡ Adrenergic release inhibitors Bethanidine Bretylium Debrisoquine Guanadrel Guanazodine Guancydine Guanethidine Guanoclor Guanoxan Imidazoline receptor agonists Moxonidine Rilmenidine Tolonidine Ganglion-blocking/nicotinic antagonists Hexamethonium‡ Mecamylamine Pentolinium Trimethaphan PeripheralIndirectMonoamine oxidase inhibitors Pargyline‡ VMAT inhibitors Bietaserpine Deserpidine Methoserpidine Reserpine Syrosingopine Tyrosine hydroxylase inhibitors Metirosine Directα1-Adrenergic receptor blockers Doxazosin Ketanserin Indoramin Prazosin Trimazosin Urapidil Non-selective α-adrenergic receptor blockers Phentolamine Other antagonistsSerotonin receptor antagonists Ketanserin Lidanserin Endothelin receptor antagonists (for PHTooltip Pulmonary hypertension) dual (Aprocitentan, Bosentan, Macitentan (+tadalafil), Riociguat) selective (Ambrisentan (+tadalafil), Sitaxentan, Sotatercept) #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III
